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Background: Despite decades of global efforts to tackle HIV-related stigma, previous
interventions designed to reduce stigma have had limited effects that were typically
in the small- to-moderate range. The knowledge gaps and challenges for combating
HIV-related stigma are rooted both in the complexity of the stigma and in the limitations
of current conceptualizations of stigma reduction efforts. Recent research has shown
the promise of resilience-based approaches that focus on the development of strengths,
competencies, resources, and capacities of people living with HIV (PLWH) and their
key supporting systems (e.g., family members and healthcare providers) to prevent,
reduce, and mitigate the negative effects of stigma. However, the resilience-based
approach, while hypothesized, has rarely been empirically tested in large intervention
trials, especially in resource-limited settings.
Methods: In this study, we propose to develop, implement, and evaluate a
theory-guided, multilevel, multimodal resilience-based intervention via a stepped wedge
cluster randomized trial among 800 PLWH and their biological or surrogate family
members, as well as 320 healthcare providers in Guangxi, China with a longitudinal
follow-up period of 36 months at 6-month intervals. The primary outcome will be viral
suppression and the intermediate outcomes will include perceived stress and medication
adherence of PLWH as well as resilience measures at the level of the individual, the family,
and the healthcare system.
Discussion: The proposed study will be one of the first large scale efforts to examine
whether resilience among PLWH can be fostered and sustained through a multilevel
and multi-component HIV-related stigma intervention and whether a resilience-based
intervention can improve clinical outcomes and quality of HIV care among PLWH in
a low-resource setting. If efficacious, the intervention components could be tailored
to other groups of PLWH and adapted for other low- and middle-income countries.
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Trial Registration: This trial is registered at ClinicalTrials.gov, registration number
NCT05174936, registered 13 December 2021. https://register.clinicaltrials.gov/prs/app/
action/LoginUser?ts=3&cx=-jg9qo2.
Keywords: HIV, stigma, resilience, intervention, stepped wedge cluster randomized trial, viral suppression

INTRODUCTION

persistent in multiple cultural settings and the gains from HIVrelated stigma reduction initiatives have often been modest and
rarely implemented at scale (7).
Many of the existing knowledge gaps and challenges for
combating HIV-related stigma are rooted in the complexity of
the stigma and in limitations in current conceptualizations of
stigma reduction efforts (11–13). The focus of most existing
intervention research on HIV-related stigma has primarily
targeted HIV-negative populations with a goal of eradicating or
reducing HIV-related stigma against PLWH and their families.
However, HIV-related stigma, like other types of social stigma,
has proven difficult to eradicate at the population level. This
suggests that, in addition to continued efforts to decrease HIVrelated stigma globally, interventions are also needed to help
individuals targeted by stigma and discrimination, such as
PLWH, to cope with stigma-related challenges (e.g., negative
interpersonal experiences, stress) (1, 12). As such, based on
their HIV Disparities Model and evidence from the global
literature, Earnshaw and colleagues proposed a resilience agenda
and suggested “enhancing resilience to societal stigma at the
individual (e.g., PLWH, family members) and structural levels
(e.g., healthcare settings) as a critical strategy to reduce HIV
disparities” (page 231) (3). Recent multi-country analyses of data
from the PLWH Stigma Index 2.0 also suggest that multilevel
interventions are a promising approach to promote resilience
among PLWH and to support PLWH engaging in services,
adhering to ART, achieving and maintaining viral suppression,
and achieving high quality of life (14, 15).
Resilience in the face of adversity or stress is a necessary
capacity of human development (16, 17). Over the past three
decades, the definition of resilience has evolved from the view of
resilience as an individual personality trait (18), to an ecological
view that resilience is a dynamic, multidimensional construct
that incorporates bidirectional interaction between individuals
and their environment (e.g., family, peers, community, society)
(6, 18). Resilience can be cultivated or enhanced in an individual’s
life by the presence of one or more protective factors, such
as close relationships with competent and caring partners in
family and healthcare settings, a range of problem-solving skills,
and a variety of psychological dispositions (e.g., self-esteem,
self-confidence, positive future orientation) (9–20). Available
data suggest the promises of these protective factors to foster
resilience and mitigate the negative effect of stigma on HIV
clinical outcomes (21, 22). The global literature has suggested
the critical role of family members [either of origin (e.g., parents,
spouse, siblings) or of choice (e.g., non-kin individuals who serve
a family-like role by providing emotional or other support)]
(23, 24) as a “network of mutual commitment” in assisting PLWH
in achieving viral suppression and coping with HIV-related

The finding from the HPTN 052 trial of a 96% reduction in
HIV incidence among discordant couples when the HIV-positive
partner receives antiretroviral therapy (ART) has led to the
emergence of “treatment as prevention” as the dominant strategy
to end the global HIV epidemic (1–3). However, numerous
obstacles continue to prevent appropriate treatment and optimal
clinical outcomes, including stigma against people living with
HIV (PLWH). This is a significant public health problem
worldwide, particularly in low- and middle-income countries
(LMICs), including China. Stigma and discrimination related to
HIV and AIDS (i.e., “HIV-related stigma”) can be multifaceted
(e.g., individual, community, and institutional) and lead to
detrimental impacts, such as preventing PLWH from seeking
and receiving appropriate treatment and care, contributing to
psychiatric disorders (e.g., depression) and low quality of life, and
producing poor clinical outcomes among PLWH (4–6).
Despite substantial global efforts to reduce HIV-related
stigma, stigma and discrimination remain persistent and
widespread and are among the most poorly understood aspects
of the epidemic (7). Two earlier systematic reviews of HIVrelated stigma reduction interventions conducted in almost
30 countries across a time span of 20 years (8, 9) identified
numerous gaps in evidence-based interventions to reduce HIVrelated stigma. These gaps included insufficient engagement
of PLWH, only targeting a single socioecological level or a
single domain of stigma, inadequate measures to evaluate HIVrelated stigma reduction, limited public health relevance of
the findings (e.g., lack of clinical endpoints), and a lack of
rigor in research methodology. Likewise, Rao et al. in their
2019 review (10) of 24 multilevel stigma interventions around
the globe confirmed that the effects of these interventions
varied widely in magnitude and were typically in the smallto-moderate range. The authors acknowledged that while there
has been progress over the past decade in developing and
evaluating multilevel stigma interventions, much work remains
to strengthen and expand this approach. A collection of studies
in the 2020 AIDS special issue titled “Reducing stigma and
discrimination: innovation in measurement and practice” also
suggested that HIV-related stigma remains highly relevant and

Abbreviations: AIDS, Acquired Immunodeficiency Syndrome; ART,
Antiretroviral Therapy; ARV, Antiretroviral; AZT, Zidovudine; CDC, Centers
for Disease Control and Prevention; EFV, Efavirenz; HCP, HealthCare Providers;
LPV, Lopinavir; LMICs, Low- and Middle-Income Countries; MSM, Men Who
Have Sex With Men; NVP, Nevirapine; PLWH, People Living With HIV; POL,
Popular Opinion Leaders; RTV, Ritonavir; SEM, Structural equation modeling;
TFV, Tenofovir; 3TC, Lamivudine.
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resilience and produce improvement in intermediate outcomes
(e.g., stress, medical adherence) and endpoint clinical outcomes
among PLWH. The framework emphasizes individual and
contextual factors (including diverse family structures and risk
profiles) that may mediate or moderate the effects of the
proposed intervention (13, 27). The framework also provides a
“blueprint” that guides our measures for each of these critical
domains and our analytic plan to test intervention effects and
potential individual and contextual mediators and moderators of
such effects.

stigma (25, 26). The role of supportive family members in
coping with HIV-related stigma appears especially salient in
collectivistic societies such as China, where socio-cultural norms
emphasizing the individual’s obligation and responsibility to the
family and community may indirectly facilitate the manifestation
of HIV-related stigma. These findings indicate that interventions
for HIV-related stigma can benefit from taking into account
culturally appropriate intra- and interpersonal protective factors
and seeking to actively enhance these resilience factors.
Healthcare providers (HCPs) can also play an essential
role in promoting resilience against HIV-related stigma. While
healthcare systems in China and other LMICs are facing
increasing demands to provide quality care to a growing
population of PLWH, healthcare settings are often the places
where PLWH experience stigma and discrimination (27, 28).
Because of the critical importance of engaging in HIV care for
PLWH’s quality of life and clinical outcomes, global literature has
suggested the value of supportive healthcare systems, including
HCPs, across various HIV epidemics and socio-cultural settings
(28, 29). Previous work in both China (30–32) and other
countries (33–38) has shown that interventions among HCPs
can reduce HIV-related stigma by improving their knowledge
about the prevention and treatment of HIV and AIDS, as well
as their willingness to treat and support PLWH, which can lead
to better quality of care for PLWH. Recent research, including
our own preliminary data (39–43), has suggested the potential
utility of adopting a resilience-based approach that focuses
on the development of strengths, competencies, resources, and
capacities in PLWH, as well as their families and healthcare
systems to reduce and actively mitigate the negative effects of
stigma. However, this approach, while hypothesized, has not been
sufficiently tested in longitudinal studies or large intervention
trials, especially in low-resource settings.

AIMS AND OBJECTIVES
This study proposes to develop, implement, and evaluate
a theory-guided, multilevel, multimodal resilience-based
intervention via a stepped wedge cluster randomized trial among
800 PLWH and their biological or surrogate family members,
as well as among 320 healthcare providers in Guangxi Zhuang
Autonomous Region (“Guangxi”), China with a longitudinal
follow-up over a period of 36 months with 6-month follow-up
intervals. The specific aims are to:
(1) Develop a multilevel resilience-based HIV stigma reduction
and mitigation intervention program (“RISE-UP”) engaging
PLWH, their biological or surrogate family members, and
healthcare providers (HCPs). The RISE-UP intervention will
target individual factors (e.g., resilience, self-efficacy), family
factors (e.g., supportive family members), and structural
factors (e.g., supportive HCPs and care facilities) by
adapting existing intervention components that have shown
preliminary efficacy in China or elsewhere.
(2) Test the short-, medium-, and long-term efficacy of the
RISE-UP intervention through a stepped wedge cluster
randomized trial among 800 PLWH-family member dyads
and 320 HCPs from ∼40 HIV clinics in Guangxi with a
longitudinal follow-up over a period of 36 months at 6month intervals.
(3) Identify individual and contextual factors that may mediate
or moderate the effect of RISE-UP intervention on viral
suppression, other clinical outcomes (e.g., CD4), and the
intermediate psychosocial and behavioral outcomes (e.g.,
resilience, stress, medication adherence, quality of life).

CONCEPTUAL FRAMEWORK
Figure 1 presents a multi-component, multi-level conceptual
framework we developed that depicts the process of HIV stigma
manifestations and role of resilience development in mitigating
the negative effects of stigma on psychological, behavioral, and
clinical outcomes. This framework is culturally adapted from
an existing resilience-based intervention conceptual framework
(20) by (1) specifically targeting PLWH and two key supporting
sources in their lives, and (2) using HIV-related clinical outcomes
as endpoint measures. Guided by the core principles of the
socio-ecological model of human development (44), positive
psychology, and theories of resilience (45), this model focuses
on the dynamic process of resilience within the cultural context
of multi-layered HIV stigma and emphasizes the centrality of
individual assets and supportive social contexts in resilience
development (46). Support from family members and HCPs,
two critical entities in the context of HIV care and HIV-related
stigma, can foster the development of PLWH’s internal assets
(e.g., self-esteem, self-efficacy, positive future orientation). A
positive impact of the proposed intervention on supportive
social contexts and PLWH’s internal assets will in turn develop
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METHODS/DESIGN
Population and Setting
Research Setting
This proposed study will be conducted in Guangxi, one of the
regions in China that is experiencing the fastest growth of the
HIV epidemic. A total of 10,060 new HIV cases were reported
in Guangxi in 2020 with a male to female ratio of 2.66:1.
The HIV epidemic in Guangxi is characterized by: (1) sexual
transmission (97.8% of all cases, including 90.5% heterosexual
transmission and 7.3% male-to-male sexual transmission); (2)
rural residents (72.6%); (3) low education levels (84.9% ≤ middle
school education, including 7.3% with no formal education,
44.6% with elementary school education only, and 33.1% with
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FIGURE 1 | Conceptual framework [adapted from Li et al. (20)].

PLWH Intervention

middle school education only); and (4) late diagnosis (52.0%
of newly reported cases were AIDS patients). More than half
(54.1%) of the cases were married, followed by divorced or
widowed (21.4%). Individuals ≥50 years of age accounted for
51.0% of all the cases living with HIV.

The primary goal of the PLWH intervention is to assist
PLWH in identifying and developing internal and external
resilience resources to aid in coping with HIV stigma (including
layered stigma), to mitigate the negative impacts of HIV
stigma, and to improve their clinical health outcomes. The
intervention curriculum will consist of five interactive training
sessions (2 h each) with four specific areas of resiliencebuilding: individual assets (self-esteem, emotion regulation,
positive future orientation), coping with a chronic health
condition (medical adherence, stress reduction, healthy lifestyle,
self-care), relationship building (family relationship, providerpatient relationship), and social support (identifying and seeking
social support at various socioecological levels). Each session
will address one or more of these areas through interactive
learning activities (multimedia presentations, role-plays, group
discussions, games, personal testimonies). The curriculum will
also address empowerment at both individual and family levels
across sessions.

Selection of Participating Sites
In Guangxi, geographic units important for our study design
include cities that are composed of urban districts, as well as
rural counties that are composed of rural townships. There is
one designated primary public hospital with an HIV clinic in
each urban district and rural township that works under the
direction of the city or rural county Center for Disease Control
and Prevention (CDC) to conduct clinical management and
semi-annual follow-ups for all PLWH in the district or township.
In collaboration with Guangxi CDC, we will select two cities and
eight rural counties that have the largest number of reported
HIV cases to participate in our proposed study. Guangxi CDC
will identify all urban districts in the two cities and all rural
townships in the eight rural counties that have at least 200 HIV
cases. We will randomly select 42 of them (stratified by urban vs.
rural) as our project sites (2 for pilot-testing; 40 for the actual
intervention trial).

Family Member Intervention
The format of the family member intervention will be similar
to the PLWH intervention but will emphasize providing social
support for PLWH’s resilience building as well as fostering
resilience at the family level. The intervention will consist of
five sessions of group activities (2 h each), with each session
addressing one or more of the following areas: (1) HIV and
ART knowledge [utilizing “undetectable equals untransmissible”
[U=U] messaging]; (2) support to strengthen the capacity of

Intervention Components
Our proposed multilevel and multimodal resilience-based
intervention program includes: (1) a PLWH component; (2) a
family member component; and (3) an HCP component.

Frontiers in Public Health | www.frontiersin.org
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feasibility and acceptability. Based on the results of the pilot
testing, a workshop will be held with the intervention facilitators
and the US-China research team to finalize changes to the
curricula for incorporation into the facilitator manuals and
implementation protocols.

PLWH and their family members to adapt to living with
HIV; (3) relationship building (family relationships, intimate
relationships); (4) emotional and behavioral support for PLWH’s
adherence to care and treatment, including tailored coping or
support strategies to address unique needs of some participants
who may be more prone to HIV stigma (e.g., sexual and gender
minorities and their family members); and (5) self-care. With
appropriate consent from both the PLWH and family members,
PLWH will be invited to join with family members for two of the
five sessions (i.e., relationship building and adherence support)
with the goals of improving the interactions of PLWH with family
members and discussing common issues and challenges faced by
both parties.

Pilot-Test the Assessment Instruments
Most of the demographic, psychosocial, and behavioral
measurements we have selected for PLWH, family members, and
HCPs in this study were field-tested and validated previously
in China and have been shown to be reliable and valid for their
stated purposes. The measures will be further modified based
on the specific aims of this study and global literature on stigma
and resilience research among PLWH (21, 22, 48–51). The final
drafts of all measures will be reviewed and pilot tested among 40
PLWH, 40 family members, and 20 HCPs to obtain perspectives
from the target populations on the clarity, cultural sensitivity,
and appropriateness of relevant measures. Pilot testing will
follow the same recruitment and consenting process as the actual
intervention trial.

HCP Intervention
The HCP intervention will have two primary goals: reducing
HCP’s stigmatizing attitudes and practices toward PLWH and
other social identities such as sexual and gender minorities, sex
workers, and injection drug users, and improving the providerpatient relationship. The HCP intervention will consist of four
1.5-h sessions addressing the following topics: (1) universal
HIV precautions and occupational safety; (2) layered stigma
against PLWH (e.g., manifestations of layered stigma in clinical
settings); (3) best practices in building a good provider-patient
relationship (e.g., reducing stigmatizing attitudes and behaviors
toward PLWH, respecting patients’ rights for privacy related
to care and disclosure); (4) best practices in providing high
quality patient care for PLWH (e.g., increasing skills and
comfort in working with PLWH); (5) building a supportive
medical environment for better care of PLWH; and (6) skills
and confidence in delivering stigma reduction messages to
coworkers. The HCP intervention will adapt Popular Opinion
Leaders (POL) principles by teaching participants skills for
initiating/disseminating stigma reduction messages/practices to
colleagues in the workplace (47). The sessions will also be
highly interactive with role-plays, facilitator modeling, group
discussions, games, testimonies, and presentations from PLWH
and medical experts.

INTERVENTION TRIAL
Eligibility Criteria
PLWH
The eligibility criteria for PLWH include: (1) aged 18 years or
older; (2) at least 3 months since confirmed diagnosis of HIV
and/or AIDS; (3) detectable viral load (e.g., viral load ≥50
copies/mL) or a viral round during the past year (i.e., a confirmed
detectable viral load following a suppression); (4) willing to refer
or give permission for us to contact one of their adult family
members (either of origin or of choice) to participate (but the
decision to participate will solely reside in the family member);
(5) willing to provide a hair sample for testing hair cortisol, hair
antiretroviral (ARV) concentration, and relevant biomarkers; (6)
willing to consent for the retrieval of past viral load and CD4
count data from their medical records; and (7) willing to be
randomized to receive the intervention at different time points in
the stepped wedge trial. The exclusion criteria for PLWH include
(1) cognitive or physical inability to respond to assessment
questions or to participate in intervention; (2) currently
incarcerated or institutionalized for drug use or sex work; (3)
participating in other intervention activities during the current
study period; and (4) plan to permanently relocate outside of
the province within a year. Mental and physical inability will
be screened by the local research team in consultation with
physicians at the participating clinics.

PILOT-TESTING
Pilot-Test the Intervention Curricula
All intervention protocols will be reviewed by our community
stakeholders for cultural appropriateness, acceptability, and
perceived feasibility. In addition, the intervention curricula will
be pilot-tested among 30 PLWH (10 females and 20 males), 30
family members (15 biological family members and 15 family
members of choice), and 20 HCPs (8 physicians, 12 nurses
or other healthcare professionals). These participants will be
recruited from the two clinics (one urban and one rural) that
will not participate in the actual intervention trial, and the pilot
test will adhere to the same inclusion/exclusion criteria of the
actual intervention trial. The main purposes of the pilot test
are to assess the comprehensibility of the curriculum; cultural
appropriateness of the vignettes, materials, and activities for
the target population; and logistics of the implementation (e.g.,
timing of each session) in order to further improve the program’s

Frontiers in Public Health | www.frontiersin.org

Family Members
The eligibility criteria for family members include (1) aged 18
years or older; (2) either family member of origin or
family member of choice who provides emotional and other
social support to PLWH enrolled in the study; and (3)
willing to be randomized (along with PLWH enrolled in the
study) to receive intervention at different time points. The
exclusion criteria for family members will be the same as for
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permission from site leaders, we will stratify the HCPs in a
clinic by profession (physicians vs. other) and professional rank
(high/middle vs. low) and randomly approach providers in each
stratum, explain the study design following a standard script, and
invite them to participate. Local team will meet with interested
providers (along with site leaders if desired by providers) to
answer questions related to schedule, site support, and other
logistic issues related to their participation in the study.

PLWH. The decision of a family member to or not to participate
will not affect the eligibility of PLWH.

HCPs
The eligibility criteria for HCPs include: (1) age 18 years or
older; (2) provides healthcare services at a participating
HIV clinic; and (3) has regular contact with HIV patients.
The exclusion criteria for healthcare providers include a plan to
permanently relocate outside of the province within a year.

Participants and Recruitment

RANDOMIZATION AND INTERVENTION
DELIVERY

Participants in the intervention trial will include 800 PLWH and
their family members (one per PLWH, either family of origin or
family of choice) and 320 HCPs from public HIV clinics in the
40 urban districts/rural townships. Based on our previous work
in China, we anticipate high participation rates (e.g., 90% for
PLWH, 80% for family members, and 95% for HCPs).

We will use a stepped wedge cluster randomized trial for
intervention assignment and delivery (Table 1). For logistic
reasons, the 40 clinics will be grouped into 5 clusters (8 clinics in
each cluster) in each urban/rural stratum based on the geographic
proximity. The local research team will randomly assign each
cluster to one of the 5 intervention starting dates (e.g., Month 19,
25, 31, 37, or 43) using a single sequence of random assignments
(e.g., using a shuffled deck of five cards bearing numbers from
1 to 5). The PLWH and family members will be organized into
small (and separate) groups (∼10 participants per group) in each
clinic through which to receive intervention sessions.

PLWH Recruitment
The PLWH sample will be randomly recruited from the 40
participating HIV clinics (∼20 PLWH per clinic). A systematic
random sampling procedure (52) will be used to randomly select
prospective participants from the HIV patient registries. Medical
staff or case managers at the clinics will use an arbitrary number
(e.g., the date of the month) to identify the first case to be
sampled from the list of HIV patients, and then every nth case
will be selected where n is a pre-calculated interval for each
sampling iteration (e.g., ratio of target sample size to the total #
of patients in the pool). The process will be repeated (without
replacement) until the target sample size is achieved at each
clinic. Once a prospective patient is randomly selected, the local
team members (who will visit each clinic at least twice a week
during the recruitment period) will verify and confirm their
eligibility and schedule a meeting to explain the study design
following a standardized recruitment script.

PLWH Sessions Delivery
The five 2-h PLWH intervention sessions will be delivered
over 5 weeks (one session per week) in the clinics where the
PLWH are recruited or in nearby private spaces in community
centers. Two trained facilitators will deliver the materials through
interactive trainings that include multimedia presentations,
group discussions, role-play, personal testimonies, and games.
The same two facilitators will deliver all five sessions within
a clinic to increase group cohesion and rapport with PLWH.
The day and time for sessions will be scheduled in advance,
and all participating PLWH will be able to opt in to receive a
voice or text reminder from the facilitator on the day before the
scheduled session.

Family Member Recruitment
Each PLWH who is eligible and willing to participate in the
study will be asked to refer one family member (either of
origin or of choice) who is aware of the PLWH’s HIV status to
participate in the study. The PLWH can give the name to the
local research team or bring their selected family member to the
clinic for eligibility screening. If the family member is interested,
a local study team member will meet with the family member,
explain the study design, and obtain appropriate consent. With
appropriate consent, we will collect brief information (e.g., family
structure, risk profile, and treatment profiles) for those PLWH
who either cannot identify a family member (of origin or choice)
or whose family member refuses to participate for potential
secondary analysis to inform the refinement and scale-up of the
proposed intervention in the future.

Family Member Sessions Delivery
The intervention sessions for family members will be similar to
PLWH sessions in terms of format and content and will be led
by trained facilitators. Family member intervention sessions will
emphasize supporting PLWH to cope with HIV-related stigma
and to assist them in improving their clinical outcomes. The
majority of sessions will consist of only family members, but
PLWH will join their family members for two specific sessions
(relationship building and adherence support). To improve
the participation of family members, both PLWH and family
member sessions will be scheduled on the same days in the same
location (so they can travel together). Both participating PLWH
and their family members will be consulted during the consenting
process on the optimal location and schedules of these group
sessions. Family members will also be able to opt in to receive
voice or text reminders in advance of scheduled sessions.

HCP Recruitment
We will randomly recruit 320 HCPs from the 40 participating
clinics (∼8 per clinic) where we recruit PLWH. Each of these
HIV clinics is typically staffed with 15–20 HCPs, including
physicians, nurses, case managers, counselors, and medical social
workers who have regular contact with HIV patients. With the
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TABLE 1 | Stepped wedge cluster randomized trial design.

HCP Sessions Delivery

promptly. If any discrepancy between the protocol and the actual
implementation emerges, the intervention facilitators will be
informed in a timely manner and necessary steps will be taken
to prevent deviations from the intervention protocol; and (2)
Audio-recording all sessions. The research staff will randomly
select and listen to audio recordings of 20% of the sessions
and will then complete an FPF for these recorded sessions.
These “independent” process measures will be compared with
the ones completed by the facilitators, and feedback concerning
fidelity will be provided to the facilitators promptly. Data
on the fidelity deviation (e.g., dose variation or substantial
modification of activities) will be documented as part of the
process evaluation to explore the effect of such fidelity deviation
on intervention outcomes.

The HCP intervention curriculum consists of four 1.5-h sessions
that will be delivered in small groups in the clinic-setting by
trained facilitators (i.e., health educators from Guangxi CDC).
Ideally, all of the participating HCPs in a clinic will attend
the sessions together. However, given the variation of clinical
schedules among HCPs in a primary care setting, the delivery
schedule and format will be flexible and individually tailored
(e.g., four sessions can be given at a rate of one per week or
consolidated into two longer sessions). Immediately following
randomization, the two intervention facilitators (paired for each
intervention delivery) will review scheduling and administrative
aspects of the clinics and contextualize each session as necessary
based on the providers’ workload and clinic schedule. Facilitators
will also work with providers during the consent process
to develop an individualized plan/schedule in each clinic for
assessment, intervention, and follow-up. All HCPs will be able
to opt in to receive voice or text reminders for planned sessions.

DATA COLLECTION PROCEDURES
PLWH and Family Member Surveys
Interviewers (who will be blinded to the schedule of intervention
delivery) will administer the baseline and all follow-up surveys
to participants via tablet computers. The tablet will display
and read (with a real human voice, utilizing a headset) the
survey questionnaire in a private room (e.g., doctor’s office) at
district/township hospitals where the participants are recruited.
This method will help to ensure the privacy and quality of the
data collection, and it will also help to reduce the potential impact
that varying degrees of literacy have on individual’s ability to
understand the items. Clarifications or assistance (with the tablet)
will be provided on site by the interviewers as needed. It is
estimated that the survey will take about 60–90 min to complete.
Participants will be instructed to take a short break after every
30 min of assessment or as needed.

Program Fidelity
The proposed interventions in this study are intensive and
complex, which is necessary to create and sustain meaningful
changes in participants. While challenging, adherence or fidelity
to the content and delivery of the program across clusters is
also critical. In addition to a standard implementation protocol,
which includes the uniform training and certification of the
intervention facilitators, we propose the following two steps to
assure fidelity to content and delivery of the intervention protocol
and to assess factors that influence the implementation of the
protocol: (1) Monitoring the actual intervention implementation.
Following the established procedures implemented in China
(53–61), one of the intervention facilitators will complete a
Fidelity Process Form (FPF) for each session. The FPF will
contain the essential elements and key process measures of
the intervention sessions, including content delivered, time
allocated, participation rate, and main activities covered by the
sessions. The local team staff will collect and analyze the FPF

Frontiers in Public Health | www.frontiersin.org

HCP Survey
All participating HCPs will complete baseline and follow-up
surveys. The questionnaires will be self-administered via a tablet,
and interviewers will be present during the survey to provide
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intervention. These measures may include socioeconomic
status, family composition, HIV diagnosis history and treatment
history, co-infection, HIV-infection among partners or other
family members, and experience of treatment side effects (for
those PLWH on ART).
Measures for HCPs at both the individual level and
institutional level. The individual level measures to be completed
by HCPs will include: (1) attitudes and behaviors toward PLWH;
(2) attitudes toward privacy or confidentiality protection (88);
(3) comfort and self-efficacy in supporting PLWH in their
treatment and adherence (88); (4) perceptions of patients’ rights
to HIV testing and disclosure; (5) perceived provider-patient
relationship; (6) knowledge and practice of universal precautions
(31); and (7) provider mental health [e.g., depressive symptoms
(CES-D) (79, 80), burnout]. The institutional level measures
will include both HCP’s perceptions and actual observations of
facilities’ efforts and environments (e.g., policy, guidelines for
clinical practice) to integrate stigma reduction into facility culture
and clinical practice (89, 90). These measures may include: (1)
presence of leaders/team of stigma reduction “champions;” (2)
presence of code of conduct and patient “rights;” (3) presence
of anti-stigma posters; and (4) presence of additional supportive
resources for PLWH and their families.

necessary clarification. It is estimated that the HCP survey will
take about 30 min to complete.

Hair Sample Collection
The collection of hair samples from all consenting PLWH at
baseline and each annual follow-up will follow the Society of Hair
Testing guidelines for drug testing in hair (62). Specifically, 1cm hair sample (20–30 strands of hair for each sample) will be
cut as close to the scalp as possible from the vertex posterior
region. The hair thatch then will be completely enclosed by a
piece of foil and be sealed into an individual plastic bag labeled
with the participant ID. Each hair collection process takes about
2 min. All hair samples will be stored at room temperature prior
to shipment to the laboratory for process and assays. Laboratory
assays using liquid chromatography/tandem mass spectrometry
(LC/MS/MS) methods have been developed and validated to
analyze most commonly prescribed ARVs in China such as
lamivudine (3TC), lopinavir (LPV), ritonavir (RTV), zidovudine
(AZT), nevirapine (NVP), efavirenz (EFV), or tenofovir (TFV) in
hair samples (63, 64).

KEY STUDY VARIABLES
Primary measures for PLWH will include: (1) HIV clinical
indicators (viral load, CD4 count, and disease progression using
the HIV staging system by WHO) to be collected from their
medical records with consent; (2) HIV-related stigma, including
perceived (or anticipated) stigma, internalized stigma, enacted
stigma (65–68), as well as layered stigma against other social
identities (e.g., sexual and gender minority, sex work, drug use,
migratory status, or poverty); (3) Resilience-related measures of
PLWH [coping strategies (69, 70), positive future expectation
(71), hopefulness for the future, perceived control over the
future (71), personal resilience strengths (72), self-concept (73),
relationship self-efficacy (74), emotional regulation (75), selfesteem (76)], family support (perceived emotional support and
adherence support, quality of relationship) (77), community
support [perceived social support (78)], and healthcare systemrelated support (perceived acceptance and trust from healthcare
facilities and HCPs, quality of provider-patient relationship).
Intermediate measures for PLWH and family members will
include (1) stress and mental health [self-report measures of
depressive symptoms (CES-D) (79, 80), anxiety (81), and stress
[Perceived Stress Scale] (82), and stress-related biomarkers [i.e.,
hair cortisol]]; and (2) adherence to clinical appointments and
medication [both self-report (83, 84) and hair ARV concentration
for PLWH who are on ART for at least 4 weeks]. In addition,
both PLWH and their family members will complete measures
of substance use [tobacco use, alcohol use (AUDIT) (85), and
other drug use], sexual behavior and reproductive health, HIVrelated quality of life (MOS-HIV) (86), and HIV disclosures
(77, 87).
Individual and contextual characteristics (potential
moderators). Measures we have used in previous studies
will also be utilized in this study to collect information from
PLWH and their family members on individual and contextual
characteristics that may potentially moderate the effect of
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POWER ANALYSIS
Because of the absence of empirical data on the effect of
resilience-based stigma reduction and mitigation intervention
in China or any other LMICs, we will conservatively assume
a “smaller-than-medium” effect size (Cohen d = 0.35) for the
long-term effect (i.e., 36-month follow-up) of our proposed
intervention on the primary PLWH outcomes [e.g., CD4 and
viral load in terms of continuous measures (log transformation)
and categorical measures (e.g., <500 vs. ≥500 for CD4; detectable
vs. undetectable for viral load)]. According to the sample size
estimation procedure developed for conventional parallel cluster
trials by Cohen (91), 140 participants are needed in each cell
(or a total 280) to detect an effect size of 0.35 (Cohen d) in
various PLWH outcomes at 36-month follow-up with a twotailed test at alpha = 0.05 and a power of 0.80. However, since
the unit of randomization in the current study is the clinic, the
sample size calculation, assuming that the unit is the individual,
needs to be adjusted for clustering and design effects. Woertman
et al. developed a formula to adjust for the design effects of
both clustering and the stepped wedge design (DEsw) (92): DEsw
= (1+ρ(ktn+bn-1))/(1+ρ(1/2 ktn+bn-1))·(3(1-ρ))/(2t(k-1/k));
where ρ is the ICC, k is the # of steps, t is the # of measurements
after each step, n=#of individuals per cluster; and b is the # of
baseline assessments. Because no clinic level ρ is available in the
literature, we conservatively assume a large ρ = 0.10 for clustering
effect (for 2 groups in each of the 40 clinics with ∼10 PLWH
per group). According to Woertman’s procedure (92), a sample
size of 528 is needed to produce an effect sample size of 280 with
an ρ =0.10. Based on an assumed 10% annual attrition, n= 800
at baseline will produce a sample size of 583 by the 36-months
follow-up. Thus, our sample of 800 at baseline (or 583 at 36
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the Sobel test, as specified by MacKinnon and Dwyer (98), will be
used to determine the significance of the mediation effect. To test
the moderation effect of contextual factors, we will also follow the
procedure suggested by Barron and Kenny (97). We will employ
multiple regression analyses and test the significance of the
appropriate interaction terms between intervention status and
the potential moderators (e.g., PLWH’s gender, sexual identity,
migratory status, family structure, risk profile, or disease stage) so
that the future scale-ups of the intervention can be appropriately
informed. Structural equation modeling (SEM) using LISREL
will be employed as a complementary methodology to conduct
mediation and moderation analyses (99, 100).

months follow-up) will provide adequate power to test the main
hypotheses in this study.

DATA ANALYSIS
The stepped wedge design offers some analytic advantages in
assessing the intervention effects: (1) The intervention effects can
be estimated from both between- and within-cluster comparisons
with clusters acting as their own controls; and (2) clusters will
receive the intervention at varying time points, providing more
flexibility in modeling the effects of intervention timing or
consistency in effect across clusters (93).

Testing Primary Hypotheses
DISCUSSION

The evaluation of the short-, medium-, and long-term efficacy
of the proposed intervention will be based on the “intent-totreat” model. Following the recommendations by Hussey and
Hughes (93), the hypothesized intervention effect on PLWH,
family member, and HCP outcomes will be assessed using
multivariable statistical methods for data from stepped wedge
design, including Mixed Effect Model (SAS procedure PROC
MIXED) for continuous outcome measures and the Generalized
Linear Mixed Effect Model (PROC GLIMMIX) for categorical
outcome measures. The mixed effect analysis approach is
advantageous for assessing the intervention’s effect since it
accounts for a number of key factors, including hierarchical
data structure, intraclass correlation (ICC) due to cluster
randomization, potential baseline differences in the outcome
measures, correlated data due to repeated measures over time,
and missing data due to attrition (94–96). In conducting these
model-based analyses, exposed (intervention) and unexposed
(control) observation periods in the stepped wedge design
will take the place of “arms” (i.e., intervention assignment) in
conventional parallel cluster trials (93). A significant interaction
between the intervention and time will be used as the evidence
of an intervention effect. The stepped wedge design will also
allow us to examine the way in which the intervention effect
develops over time once it is introduced into a cluster and allow
us to explore the variation of intervention effects among clusters,
using within-cluster comparison of unexposed and exposed
observations (93).

The limited success of existing HIV stigma reduction efforts
requires new approaches that move beyond existing practice (8, 9,
13, 101). This study applies an innovative stepped wedge cluster
randomized trial, provides an alternative to an “eradicationonly” approach, and broadens our conceptualization to include
both reduction of stigma and development of resilience. The
proposed intervention focuses on the strengths, competencies,
resources, and capacities in PLWH, their families, and HCPs in
not only reducing HIV-related stigma but also actively mitigating
the negative effects of stigma. The proposed study will develop
a culturally appropriate, effective, and sustainable intervention
modality that extends beyond the level of individual PLWH
to include interpersonal, structural, and social determinants of
HIV-related stigma. The resilience-based approach focusing on
building the strengths of PLWH and their key social support
systems is particularly appropriate within the cultural context of
China and other LMICs where PLWH and their family members
are often strongly marginalized and discriminated and often face
layered stigma which poses significant challenges to behavioral
interventions that aim to eliminate or eradicate such layered
stigma (88, 102–107). Informed by both positive psychology and
socio-ecological theory, our conceptualization of a resiliencebased intervention is a critical step in both understanding
resilience within the multiple contexts of PLWH, their families,
and their HCPs and improving clinical and other health-related
outcomes of PLWH.
The RISE-UP intervention will help PLWH to enhance
their personal strengths by providing skills-based training in
adaptive coping, problem-solving, relationship building, and
social support utilization in a group setting that fosters peer
social support. The building of internal strengths among PLWH
will be further supported and strengthened by efforts that
engage family members and HCPs. According to resilience
theory, these two key social support systems are critical for
successful adaptation to adversity; the internal strengths and
the presence of strong support systems from family members
and healthcare facilities will improve PLWH’s psychological
health (e.g., decreased symptoms of anxiety and depression,
reduced stress, improved future orientation) and will increase
PLWH’s engagement in HIV care and adherence to ART; and the
improvement in psychological health and treatment adherence

Mediation and Moderation Analyses
Mediation will be tested using the methodology developed
by Baron and Kenny (97). The method is based on multiple
regression models focusing on the predictor (e.g., intervention
status), the mediator (e.g., improvement in intermediate
outcomes), and the primary intervention outcome. According to
Baron and Kenny (97), a mediation effect is identified in line
with three conditions: (1) the predictor is significantly associated
with the outcome; (2) the predictor is significantly associated
with the mediator; and (3) the effect of the predictor on the
outcome is significantly reduced in magnitude after including
the mediator in the model. The PROC MIXED and PROC
GLIMMIX procedures will be used to perform these analyses
with continuous and categorical data, respectively. In addition to
regression analyses (i.e., PROC MIXED and PROC GLIMMIX),
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publish the data in international and national scientific journals
and present the study findings at national and international
scientific meetings and conferences. We will capitalize on social
media and professional networks that can increase the reach
and accessibility of findings, such as open access publication,
webinars, files and videos available on websites and publicly
available channels (e.g., YouTube), to increase visibility and
impact of the scientific publications and presentations; Third,
impact on policy. The dissemination efforts of this project will
extend beyond the scientific arena and will also target policy
makers in China at local (participating sites), regional (Guangxi)
and national levels through various policy forums, policy papers,
and special presentations. We hope that the anticipated success
of the proposed project will prompt policy changes in HIV
prevention, treatment and care in China and the lessons learned
from the project and the tested intervention strategies (curricula,
delivery, and evaluation) can be scaled-up to improve health
outcomes of PLWH in China and other LMICs.

will further improve PLWH’s immune functioning, which in
turn will improve PLWH’s viral suppression and other clinical
outcomes (e.g., CD4 count, quality of life) and prevent disease
progression, as well as prevent spread of HIV to others (U=U)
and end the HIV epidemic.
One of the challenges associated with conducting longitudinal
studies is attrition. Effective strategies that engage and retain
cohort participants are critical to the integrity of research
outcomes. Significant and systematic attrition can reduce the
generalizability of outcomes and the statistical power to detect
effects of interest. The effective retention strategies in this study
will include: (1) An individualized follow-up plan. Because of
the diversity in PLWH’s living situations and daily schedules,
we will advise the participants during the consenting process
that they will be followed over time and will consult with each
participant about the best way to maintain contact. In this way,
we will develop an individualized, flexible follow-up plan for
each participant (e.g., optimal way to contact them, optimal
time and place to meet, preferred frequency of contacts between
assessments); (2) Providing all PLWH and family members with
the local team member’s cellphone number for them to notify
research staff of any address change. In addition, we will ask
for at least three alternative contacts (i.e., relatives, friends) who
can provide information on the whereabouts of the participant
in case of relocation; and (3) Arranging telephone or online
contact or home visitation prior to each follow-up assessment
and making at least three attempts at contact if a PLWH or family
member cannot be located. For confidentiality reasons, none of
the communications to alternative contacts will reveal the nature
of the study.
Guided by the conceptual framework, we hope that
the proposed multilevel and multimodal resilience-based
intervention can mitigate the negative effects of HIV-related
stigma on the clinical outcomes of PLWH. The proposed
program is informed and supported by the extant global
literature on HIV-related stigma reduction, resilience research,
and our preliminary data. Findings from this rigorously designed
study are anticipated to inform future interventions and
evidence-based policymaking by identifying strategies to build
on the strengths of PLWH and their socio-ecological systems in
resource-limited settings.
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